Cultures of HEp-2 cells persistently infected by human respiratory syncytial virus differ in chemokine expression and resistance to apoptosis as compared to lytic infections of the same cell type (Q39864100)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 April 2009

Language	Label	Description	Also known as
English	Cultures of HEp-2 cells persistently infected by human respiratory syncytial virus differ in chemokine expression and resistance to apoptosis as compared to lytic infections of the same cell type	scientific article published on 5 April 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Cultures of HEp-2 cells persistently infected by human respiratory syncytial virus differ in chemokine expression and resistance to apoptosis as compared to lytic infections of the same cell type (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

respiratory syncytial virus

object named as

human respiratory syncytial virus

1 reference

based on heuristic

inferred from title

author name string

Isidoro Martínez

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Luis Lombardía

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Cristina Herranz

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Blanca García-Barreno

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Orlando Domínguez

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

José A Melero

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

5 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

388

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

31-41

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Interleukin-10 determines viral clearance or persistence in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

The many roles of chemokines and chemokine receptors in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Respiratory viral infections in immunocompetent and immunocompromised persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Cell death: critical control points

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Persisting viruses and chronic inflammation: understanding their relation to autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Resolution of a chronic viral infection after interleukin-10 receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

The Development of Balb/c Cells Persistently Infected with Respiratory Syncytial Virus: Presence of Ribonucleoprotein on the Cell Surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Persistence of respiratory syncytial virus in macrophages alters phagocytosis and pro-inflammatory cytokine production.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

A time to kill: viral manipulation of the cell death program

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Persistent of respiratory syncytial virus in human dendritic cells and influence of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Establishment of Persistent Infection by Parainfluenza Virus Type 3: Role of a Syncytium Inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Persistent infection of mouse cells with Sindbis virus: role of virulence of strains, auto-interfering particles and interferon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Innate immune responses in respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Respiratory syncytial virus inhibits granulocyte apoptosis through a phosphatidylinositol 3-kinase and NF-kappaB-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Structural basis of integrin regulation and signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Reduced expression of surface glycoproteins in mouse fibroblasts persistently infected with human respiratory syncytial virus (HRSV).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Immunohistological demonstration of respiratory syncytial virus antigens in Paget disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Activation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Induction of CD95 (Fas) and apoptosis in respiratory epithelial cell cultures following respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Cyclic production of vesicular stomatitis virus caused by defective interfering particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Productive infection of isolated human alveolar macrophages by respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Characteristics of a persistent respiratory syncytial virus infection in HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Characteristics of a respiratory syncytial virus persistently infected macrophage-like culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Latency and persistence of respiratory syncytial virus despite T cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Detection of respiratory syncytial virus (RSV) antigen in the lungs of guinea pigs 6 weeks after experimental infection and despite of the production of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Integrins as a distinct subtype of dependence receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Pulmonary peptidergic innervation remodeling and development of airway hyperresponsiveness induced by RSV persistent infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Respiratory syncytial virus inhibits apoptosis and induces NF-kappa B activity through a phosphatidylinositol 3-kinase-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Interleukin-8 mRNA synthesis and protein secretion are continuously up-regulated by respiratory syncytial virus persistently infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Significance analysis of microarrays applied to the ionizing radiation response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Establishment of respiratory syncytial virus persistence in cell lines: association with defective interfering particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Lung-specific overexpression of CC chemokine ligand (CCL) 2 enhances the host defense to Streptococcus pneumoniae infection in mice: role of the CCL2-CCR2 axis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2009.03.008

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39864100&oldid=2091710058"